|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3405495 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17702315.7 |
| Date of filing the European patent application | 2017-01-20 | |
| (97) | Date of publication of the European application | 2018-11-28 |
| (45) | Date of publication and mention of the grant of the patent | 2021-02-24 |
| (46) | Date of publication of the claims translation | 2021-08-10 |
| (86) | Number | PCT/EP2017/051153 |
| Date | 2017-01-20 |
| (87) | Number | WO 2017/125532 |
| Date | 2017-07-27 |
| (30) | Number | Date | Country code |
| 201662281217 P | 2016-01-21 | US |
| (72) |
ANDRE, Pascale, FR
BLERY, Mathieu, FR
DENIS, Caroline, FR
PATUREL, Carine, FR
WAGTMANN, Nicolai, FR
|
| (73) |
Innate Pharma,
117, Avenue de Luminy, 13009 Marseille,
FR
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Inhibitorių kelių neutralizavimas limfocituose |
| NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES |
| Payment date | Validity (years) | Amount | |
| 2024-12-18 | 9 | 208.00 EUR |
| 2026-01-20 |